Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital

References

• Edmond MB, Wisplinghoff H, Bischoff T, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–318
   PubMedGoogle Scholar
• Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005; 6: 540–547
   Google Scholar
• Davis SL, Vazquez JA, McKinnon PS. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother 2007; 41: 568–573
   PubMed Web of Science ®Google Scholar
• Bassetti M, Trecarichi EM, Righi E, et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis 2007; 58: 325–331
   PubMed Web of Science ®Google Scholar
• Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on candida species. Clin Infect Dis 1995; 20: 1526–1530
   PubMed Web of Science ®Google Scholar
• Voss A, Kluytmans JAJW, Koeleman JGM, et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15: 990–912
   Google Scholar
• Weinstein MP, Towns ML, Quartey SM. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584–602
   PubMed Web of Science ®Google Scholar
• Amrutkar PP, Rege MD, Chen H, et al. Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection 2006; 34: 322–327
   PubMedGoogle Scholar
• Gardner JS, Jarvis WR, Emori TG. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–140
   PubMedGoogle Scholar
• Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007; 44: 664–670
   PubMed Web of Science ®Google Scholar
• Dean AD, Dean JA, Burton JH, Dicker RC. Epi Info, version 6.04: a word processing, database and statistics program for epidemiology on microcomputers. Version 6.04, ed. Atlanta, GA: CDC, 1998.
   Google Scholar
• Edwards JR, Peterson KD, Andrus ML, et al. NHSN Facilities. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control 2007; 5: 290–301
   Google Scholar
• Ramirez Barba EJ, Rosenthal VD, Higuera F, et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control 2006; 4: 244–247
   Google Scholar
• Moreno CA, Rosenthal VD, Olarte N, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2006; 4: 349–356
   Google Scholar
• Rosenthal VD, Maki DG, Salomao R, et al. International Nosocomial Infection Control Consortium. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006; 8: 582–591
   Google Scholar
• Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis 2004; 38: 311–325
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996–2004. Int J Infect Dis 2007; 11: 239–244
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Park BJ, et al. Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 8: 2816–2823
   Google Scholar
• Colombo AL, Guimaraes T, Silva LR, et al. Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 2007; 5: 570–574
   Google Scholar
• White MH. The contribution of fluconazole to the changing epidemiology of invasive candidal infections (editorial). Clin Infect Dis 1997; 24: 1129–1130
   PubMed Web of Science ®Google Scholar
• Chai YA, Wang Y, Khoo AL, et al. Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital. Med Mycol 2007; 5: 435–439
   Google Scholar
• Lin MY, Carmeli Y, Zumsteg J, et al. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother 2005; 11: 4555–4560
   Google Scholar
• Presterl E, Daxböck F, Graninger W, Willinger B. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect 2007; 13: 1072–1076
   PubMedGoogle Scholar
• Sendid B, Cotteau A, François N, et al. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect Dis 2006; 6: 80
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006; 6: 21.2
   Google Scholar
• Bedini A, Venturelli C, Mussini C, et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 2006; 12: 75–80
   PubMed Web of Science ®Google Scholar
• World Health Organization. Collaborating Center for Drug Statistics Methodology. ATC Index with DDDs. OsloNorway: WHO, 2004. Available at: http://www.whocc.no/atcddd/.
   Google Scholar
• Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 662–678
   PubMed Web of Science ®Google Scholar
• Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006; 4: 1216–1224
   Google Scholar
• Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med. 2005; 9: 1928–1935
   Google Scholar
• Forrest GN, Weekes E, Johnson JK. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 2007; 12: [ Epub ahead of print]
   Google Scholar
• Brito LR, Guimaraes T, Nucci M, et al. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol 2006; 3: 261–266
   Google Scholar
• Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplant 2001; 28: 873–878
   PubMed Web of Science ®Google Scholar
• Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG. Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA 1999; 22: 2143–2148
   Google Scholar
• Alonso-Valle H, Acha O, García-Palomo JD, et al. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003; 4: 254–257
   Google Scholar
• Charles PE, Doise JM, Quenot JP, et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 2003; 12: 2162–2169
   Google Scholar
• Almirante B, Rodríguez D, Cuenca-Estrella M, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006; 5: 1681–1685
   Google Scholar